FMTX
Forma Therapeutics Holdings Inc

232
Loading...
Loading...
Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Forma Therapeutics Holdings Inc?
What is the 52-week high for Forma Therapeutics Holdings Inc?
What is the 52-week low for Forma Therapeutics Holdings Inc?
What is Forma Therapeutics Holdings Inc stock price today?
What was Forma Therapeutics Holdings Inc stock price yesterday?
What is the PE ratio of Forma Therapeutics Holdings Inc?
What is the Price-to-Book ratio of Forma Therapeutics Holdings Inc?
What is the 50-day moving average of Forma Therapeutics Holdings Inc?

Latest FMTX News

View
No FMTX news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.